Frontera Therapeutics, a clinical-stage biotech startup with operations in both China and the US, has pocketed $160 million in a Series B round of financing to bring the total fundraising size of the three-year-old firm to $195 million.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
